Diabetes Injection Pens Market, by Product Type, Geography - Global Industry Insights, Trends, Outlook, 2025

Diabetes insulin pens are advanced forms of prefilled insulin syringes and pen needles that are used to inject insulin in the body of patients suffering from type-1 diabetes. These pens usually consist of an insulin cartridge that acts as an insulin reservoir and a dial that is used to measure the exact volume of insulin that is intended to be delivered to the patient. These cartridges and pens are available in different shapes and sizes and are also available in disposable and non-disposable types. Most of the diabetes pens are incorporated with insulin pen needles that are replaceable, thin, and extremely short to reduce the pain caused during injection. Several universal pen needles are also present in the market that fits to almost all the brands of insulin pens. These pens are handy, easy to carry around, and can be used in home settings to provide accuracy in dose delivery. This in turn, is increasing the demand for diabetes insulin pens.

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/1156

Rising incidence of diabetes is expected to propel the demand for insulin injection pens

Rising incidence diabetes is one of the major factors responsible for growth of the global diabetes injection pens market. According to the American Diabetes Association, around 30.3 million of people in the U.S. suffered from diabetes, accounting for up to 9.4% of the total population in 2016. Moreover, according to the BMJ Open Diabetes Research & Care, around 387 million people in the world suffer from diabetes, out of which around 5-10% suffer from type-1 diabetes. Various other factors driving growth of the market include risk of needle-stick injuries and bacterial infection caused by regular use of syringes to inject insulin and the advancements technology related to diabetes pens, leading to development of painless devices for daily insulin injections. However, the availability of insulin patches and other substitutes for insulin delivery are expected to hamper the growth of the market.

Market Taxonomy:

On the basis of product type, the global diabetes injection pen market is segmented into:

• Insulin Pens
• Pen Needles

On the basis of usage, the global diabetes injection pens market is segmented into:

• Reusable
• Disposable

On the basis of distribution channel, the global diabetes injection pens market is segmented into:

• Hospital Pharmacies
• Retail Pharmacies
• Online Medical Stores
• Diabetes Clinics

North America to hold a dominant position in the global diabetes injection pens market, owing to advancements in technology development in the in diabetes pens

On the basis of region, the global diabetes injection pens market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global diabetes injection pens market, owing to increasing prevalence of type-1 diabetes as well as development of advanced injection pens by manufacturers in the region. For instance, according to the Centers of Disease Control and Prevention (CDC), around 5% of the people suffering from diabetes are diagnosed with type-1 diabetes and are unable to produce insulin naturally. This increases the demand for external insulin administration. Moreover, according to the Juvenile Diabetes Research Foundation, the healthcare burden due to type-1 diabetes in the U.S. accounted for up to US$ 14 billion in 2016. Asia Pacific is expected to witness fastest growth in the market, owing to rising awareness among the patients as well as evolving healthcare infrastructure.

Key players are focused on development of novel products to sustain their position in the highly consolidated market

Key players operating in the global diabetes injection pens market include Novo Nordisk A/S, AstraZeneca Plc, Biocon Ltd, Eli Lilly and Company, Becton, Dickinson and Company, and Jiangsu Delfu Co. Major players are consistently focused towards innovation and development in the existing technology to maintain their significance and establish their presence in the global diabetes injection pens market. For instance, Novo Nordisk in 2014 introduced a new insulin injection pen device NovoPen Echo that was the first-ever injection pen to deliver half a unit of insulin, with a memory function that records last dose and the time passed since the last injection.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

X-ray Market to Surpass US$ 14.4 Billion Threshold by 2025 Globally

The Global X-ray Market, by Modality (Portable and Stationary), by Product Type (Rotating Anode Source, and Fix Anode Source), by Technology (Analog, Computed Technology, and Digital Radiography (Flat Panel Detectors and High Density Line Scan Solid State Detectors)), by Applications (General Radiography, Chest Imaging, Orthopedic, Cardiovascular, Dental, Mammography, and Others), by End User (Hospitals, Diagnostic Centers, Research Centers, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 7869.4 million in 2017 and is projected to exhibit a CAGR of 7.8% over the forecast period (2017 – 2025), as highlighted in a new report published by Coherent Market Insights. Increasing incidence of fractures, orthopedic disorders, and cancer as well as advancements in technology related to X-ray system, so as to improve image quality and reduce dose technique are expected to drive growth of the global X-ray market over the forecast period.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1153

X-ray is a type of electromagnetic ionizing radiation, which has wide applications in diagnostics. Advancements in technology and new product launches of innovative X-ray system are boosting growth of the market. For instance, In October 2017, Siemens Healthineers launched new Cios Spin, a mobile C-arm in the U.S. Cios Spin mobile arm provides potential benefits as a design aid intra-operative 3D imaging. Moreover, with high generative power, it can scan the solid part of the body such as the hip and can also scan more dense tissue in obese patients. Such advancements have enabled easy and immediate viewing of images on the screen, which in turn has shifted the trend from conventional X-ray techniques to digital X-ray technique, as it does not a require processing before it can be viewed. Computed tomography (CT) scans are highly valuable during emergency cases, as they provide quick information while assessing strokes, heart diseases, and brain injuries. For instance, in April 2017, Toshiba Medical launched new Aquilion Lightning computed tomography (CT), which provides high quality images and potentially helps with faster diagnosis. However, continuous exposure to the ionizing radiation, causes cell mutations, in turn leading to increased risk of cancer. This poses as a major restraint for growth of the market for X-ray.

Browse 25 Market Data Tables and 30 Figures spread through 150 Pages and in-depth TOC on X-Ray Market by Modality (Portable and Stationary), by Product Type (Rotating Anode Source, and Fix Anode Source), by Technology (Analog, Computed Technology, and Digital Radiography (Flat Panel Detectors and High Density Line Scan Solid State Detectors)), by Applications (General Radiography, Chest Imaging, Orthopedic, Cardiovascular, Dental, Mammography, and Others), by End User (Hospitals, Diagnostic Centers, Research Centers, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025

Key Takeaways of the X-ray Market:

• The global X-ray market is expected to exhibit a CAGR of 7.8% over the forecast period (2017 – 2025), owing to the presence of high potential markets, especially in Asia Pacific, and Latin America. Whereas North America is expected to hold a dominant position in the market due to increasing problem of osteoporosis and introduction of new technologies
• Among modalities, the portable segment is expected to gain traction over the forecast period, as portable devices reduce time spent in hospitals, resulting in lower chances of contracting hospital acquired infections (HAIs)
• Among technologies, the digital radiography segment is expected to exhibit rapid growth, as digital radiography reduces radiation exposure and improves the ability to detect diseases
• Among end users, the hospital segment is expected to hold the largest market share due to the increasing prevalence of cancer, fractures, and orthopedic disorders

Some major players operating in the X- ray market are Siemens AG, Toshiba Medical Systems, Hitachi Medical Corporation, Shimadzu Corporation, Carestream Healthcare, Philips Healthcare, Canon, Inc., GE Healthcare, Bracco Imaging S.p.A, and Hologic, Inc.

About CMI

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Medical Batteries Market to Surpass US$ 3,574.9 Million Threshold by 2025 globally

The global medical batteries market by Product Type (Implantable Batteries {Pacemakers Batteries, Implantable Cardioverter Defibrillator Batteries, Neurostimulators Batteries, Cochlear Batteries, Infusion Pumps Batteries, and Other Implantable Batteries} and Non-Implantable Batteries {Diagnostic Imaging Device Batteries, Patient Monitoring Device Batteries, Critical Care Support Batteries, In Vitro Diagnostics Instrument Batteries, Therapeutic Devices, Prosthetic Device Batteries and Other Non-Implantable Batteries}), by Battery Type (Lithium Batteries, Nickel-Metal Hydride Batteries, Zinc-air batteries) and by End User (Hospitals and Nursing Homes, Clinics, Diagnostic Centers, Home Care Settings, Others) and by Region is estimated at US$ 2,181.6million in 2017 and is projected to exhibit a CAGR of 6.4 % over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1174

Increasing prevalence of chronic diseases and cardiovascular diseases is leading to continuous developments and innovation in medical devices for treatment and prevention, such as pacemakers and defibrillators.  This rise in prevalence is leading to development of light, long-life efficient batteries, mainly in patient monitoring devices such as glucometer, hemodynamic, cardiac, neuro, fetal & neonatal, respiratory, weight, temperature, multi-parameter, and remote patient monitoring devices and this is expected to lead to growth of the medical batteries market.

Manufacturers of medical batteries are focusing on new product launches to expand its product portfolio and to cater to increasing demand for batteries. For instance, MED-EL, a provider of hearing implant systems, launched first cochlear implant audio processor to feature wireless charging, in September 2017. This wireless charging enables user to power their implants with 18 hours of battery life for each four hour charge, providing the users a full day of hearing from one overnight charge. In May 2014, Vitec Group — a manufacturer of mobile power systems for healthcare industry — introduced Elora battery system. The Elora battery system is 240Wh, lithium-ion battery, which provides flexible and scalable solutions in battery management for point-of-care technology, primarily for mobile workstations such as medical carts.

Furthermore, in October 2014, Panasonic Corporation commercialized its pin shaped lithium ion battery. The pin shaped battery is the smallest cylindrical shaped rechargeable lithium ion battery, which is suitable for powering small devices such as medical devices and wearable devices.

Browse 40 Market Data Tables and 36 Figures spread through 214 Pages and in-depth TOC on Medical devices Product Type (Implantable Batteries (Pacemakers Batteries, Implantable Cardioverter Defibrillator Batteries, Neurostimulators Batteries, Cochlear Batteries, Infusion Pumps Batteries, and Other Implantable Batteries) Non-Implantable Batteries (Diagnostic Imaging Device Batteries, Patient Monitoring Device Batteries, Critical Care Support Batteries, In Vitro Diagnostics Instrument Batteries, Therapeutic Devices, Prosthetic Device Batteries and Other Non-Implantable Batteries) by Battery Type (Lithium Batteries, Nickel-Metal Hydride Batteries, Zinc-air batteries) by End User (Hospitals and Nursing Homes, Clinics, Diagnostic Centers, Home Care Settings, Others) and by Region- Global Forecast to 2025

Manufacturers are focusing on expanding the company’s presence in the medical batteries market through mergers and acquisitions strategy, which in turn is expected to favor the growth of medical batteries in near future.  For instance, in January 2016, Ultralife Corporation acquired Accutronics Ltd. for US$ 11 million in cash transaction, as Accutronics is engaged in designing, development, and manufacturing of smart battery and charger systems for devices including digital imaging, ventilators, anesthesia, endoscopy, patient monitoring, cardio pulmonary care, oxygen concentration, and aspiration. In addition to this, in February 2017, EaglePicher Technologies, LLC acquired Lithiumstart Inc. — a company engaged in offering lithium ion battery management, safety, and power conversion technology.

Key takeaways of the market:

• The global medical batteries market is expected to exhibit a CAGR of 6.4% over the forecast period (2017–2025), owing to the rising prevalence of cardiovascular disease. Asia Pacific market is expected to exhibit a high growth rate, in terms of value, over the forecast period, as the medical battery manufactures involved in the merger and acquisition activities to expand their market in Asia Pacific.
• Among battery type segments, lithium batteries is expected to exhibit fastest growth with a CAGR of 7.6% over the forecast period, due to high voltage, energy density, and unique characteristics of lithium battery system makes then a strongest battery type preferred for implantable medical devices.
• The global medical batteries market is characterized by market expansion in Asia Pacific, North America, and Europe, which is expected to generate higher market revenue due to increase in number of acquisition. For instance, EnerSys acquired the Energy Leader Batteries India Pvt Ltd. in November 2013. Moreover, the acquisitions enables EnerSys to geographically expand their medical batteries portfolio in the Asia Pacific region

Some major players operating in the medical batteries market are Ultralife Corporation, EaglePicher Technologies LLC, EnerSys, Liberating Technologies, Inc., Panasonic Corporation, Tadiran Batteries Ltd., Saft Groupe S.A., Arotech Corporation, SHENZHEN KAYO BATTERY Co., Ltd, and Vitec Group plc.

About CMI

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Ventilators Market, by Product Type, Age Group, Interface, Mode, End User and Geography - Opportunity Analysis, by 2025

A ventilator is a medical device used to support the breathing of patients. It is a form of breathing assistance in which an endotracheal tube is directed towards the airway of patient and it is connected to ventilator system. They are often used during surgery when patient is under anesthesia, which puts a patient to sleep without interrupting normal breathing. This system can be used as a diagnostic tool to measure static compliance of airway resistance and irregular functioning of respiratory system. The failure of ventilators may result in death so it is classed as life critical system and the system should be highly reliable.

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/1220

Increase in number of private and public hospitals attributing to the growth of ventilators market

According to World Health Organization (WHO) fact sheet 2015, around 3 million people died due to of chronic obstructive pulmonary disease (COPD), accounting for 5% of all deaths. The rising incidences of chronic diseases such as chronic obstructive pulmonary diseases (COPD), bronchitis, asthma, and increase in number of accidental cases are some of the situations where medical ventilators are used. The rising incidence rate of preterm birth, respiratory diseases, growth in geriatric population associated disorders, growing pollution level, the changing lifestyle of people and habits such as smoking and drinking leading to enhanced risk of respiratory infections, lung diseases and cancer are driving the ventilators market. According to the World Health Organization (WHO), 2017, an estimated 15 million infants are born preterm annually accounting for approximately 1 million deaths in 2015. The survey also states that three-quarters of these deaths could be prevented with the current cost-effective interventions. However, the complications associated with the use of medical ventilator such as resistance from patients and physicians for technology transition, disorders such as barotrauma, lung injury, pneumonia and high cost of medical ventilators are some of the factors restraining the growth of the global ventilators market.

Global Ventilators Market Taxonomy:

The global ventilators market is segmented as per product type, age group, interface, mode, end user and region.

On the basis of product type, the global ventilators market is segmented into:

• Portable Ventilators
• Stationary Ventilators

On the basis of technology, the global ventilators market is segmented into:

• Mechanical Ventilators
• Automatic Ventilators

On the basis of age group, the global ventilators market is segmented into:

• Adult/pediatric ventilators
• Neonatal/infant ventilators

On the basis of interface, the global ventilators market is segmented into:

• Invasive Ventilators
• Non-Invasive Ventilators

On the basis of mode, the global ventilators market is segmented into:

• Combined Mode Ventilation
• Volume Mode Ventilation
• Pressure Mode Ventilation
• Others

On the basis of end user, the global ventilators market is segmented into:

• Hospitals
• Ambulatory Care Centers
• Home Care Setting

North America dominates the ventilators market due to increasing incidence of coronary diseases

Regional segmentation of the global ventilators market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia pacific, Middle East and Africa. North America dominates the ventilators market, followed by Europe. According to the American Heart Association, 2017, about 92.1 million American adults are suffering form of cardiovascular disease or the after-effects of stroke. According to the study conducted by Department of Anesthesiology, Columbia University, 2014, ICU occupancy ranged from 57.4% to 82.1% and the number of beds filled with mechanically ventilated patients ranged from 20.7% to 38.9% in the U.S., which is driving the growth of ventilators market in North America. Aging population, investments to curb the ventilators shortage, expansion of private hospitals in rural area, and growing economy are the some of the important factors boosting the ventilators market in Asia Pacific. According to the survey by Public Library of Science, 2016, the functional mechanical ventilators were available for only half of the ICU beds (5.1 mechanical ventilators/100,000 inhabitants) in China, indicating a relevant shortage of medical resources in the healthcare settings in China.

Major players are launching technologically advanced product to hold the major share in ventilators market

Key players operating the global ventilators market include Becton, Philips Healthcare, ResMed Inc., Medtronic Plc, Dragers Group, Smiths Group Plc, Hamilton Medical, GE Healthcare, and Teleflex Incorporated. Market players are focused on launching new product to maintain lead in the ventilator market. For instance, the medical ventilator by Smiths Medical, PNEPAC Para PAC was the recent advancement approved by the U.S. FDA in 2014, which offers greater control of breathing parameters with MRI compatibility giving maximum flexibility for transport within the medical setting. The strategies such as merger and acquisition with local and international players and focus on technological advancements are adopted by manufacturers to sustain their position in the ventilators market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Urinary Catheters Market - By Product Type, Application, End User - Opportunity Analysis, 2025

Urinary catheter is a tube used to collect urine from the bladder. The catheters are mostly recommended by the healthcare providers for people suffering from bladder disorders such as urinary incontinence and urinary retention. The catheters are usually made of latex, silicone, and polyurethane. Foley catheter comprises a balloon for holding the tube in the bladder for long term, whereas intermittent catheters provides short term catheterization. The urinary catheters are inserted into the urethra guiding through the bladder to drain out urine providing convenience to patients post-surgery. External catheters are advanced catheters preventing catheter associated urinary tract infections (CAUTI). Urinary catheters are also used during long surgical procedures for urine drainage for patients with other medical conditions such as spina bifida, multiple sclerosis and spinal injury, as the patients with neurological disease are at a risk for neurogenic lower urinary tract dysfunction known as neurogenic bladder.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1198

Rising prevalence of benign prostate hyperplasia in adults is expected to drive the growth of globalurinary catheters market

The urinary catheters market is expected to grow drastically due to rising occurrence of target diseases such as benign prostate hyperplasia (BPH), urinary incontinence, urinary retention, bladder obstruction, and bladder cancers. According to the World Health Organization (WHO) estimates, 2015, over 200 million people are suffering from bladder control problems due to different diseases that essentially require urinary catheterization in 2015. According to the  National Association for Continence, one third of the men and women between the age group of around 55-65 years suffer from bladder control problem at some point in their adult life. Neurological disorders leading to bladder dysfunction also require catheters for urine drainage. The factors such as increasing genital surgeries, availability of improved catheters, and favorable reimbursement policies is expected to boost the market growth.

The urinary catheters market is expected to gain a significant traction over the forecast period with the launch of innovative catheters to minimize the rates of catheter associated infections. According to the study by Antimicrobial Resistance and Infection Control, 2014, catheter-acquired urinary infection is the source for about 20% health-care acquired infections in acute care facilities and over 50% in long term care facilities. In 2016, CompactCath launched smaller and discreet intermittent catheter aimed to address infection related complications and to improve self-catheterization experience.

Global Urinary Catheters Market Taxonomy:

The global urinary catheters market is segmented on the basis of product type, application, end user and geography.

On the basis of product type, the global urinary catheters market is segmented into:

• Foley/Indwelling catheters
• Intermittent catheters
• External catheters

On the basis of application, the global urinary catheters market is segmented into:

• Benign Prostate Hyperplasia
• Urinary Incontinence
• Urinary Retention
• Neurogenic Bladder
• Others

On the basis of end user, the global urinary catheters market is segmented into:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Increasing number of prostate surgeries is expected to dominate the urinary catheters market in North America

Regional segmentation of the urinary catheters market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. North America is expected to dominate the global market, owing to the rising cases of urinary continence and prostate surgeries. According to the American Academy of Family Physicians (AAFP) estimates in 2013, urinary incontinence affected approximately 20 million American women and 6 million American men with more than 250,000 surgical procedures carried out for benign prostatic hyperplasia (BPH). According to the Urology Care Foundation estimates in 2015, around 150,000 men in the U.S. undergo transurethral resection surgery of the prostate annually, thus increasing the demand for urinary catheters. In 2017, a national performance improvement program named Health Care-Associated Infections/Catheter-Associated Urinary Tract Infection was designed by the Agency for Healthcare Research and Quality Safety Program for Long-term Care to promote implementation of a CAUTI prevention program through state-based or regional collaborative in more than 500 nursing homes across the U.S.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/urinary-catheters-market-1198

Development of innovative products expanding patient choice is expected to rise the demand for urinary catheters market

Key players operating the urinary catheters market include Hollister Inc., Boston Scientific Corporation, Teleflex Inc., Coloplast, Cook Medical, B Braun Melsungen AG, and Medtronic. In 2016, Coloplast launched the new soft catheter SpeediCath Flex for men, which is designed for easy and hygienic insertion, making catheterization easy. Also, in 2015, Hollister Incorporated launched two new hydrophilic intermittent catheters, the VaPro Plus touch free and Apogee HC hydrophilic intermittent catheter. These catheters provides more options for healthcare professionals and the patients as they are easy-to-carry and store.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Tissue Diagnostic Market by Product Type, Technology, Disease, and End User - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types of cancer conditions. Recognition of sign and symptoms of disease are done through biopsy, a process of taking sample from region of interest such as skin, tissue or tumor for further diagnosis. Biopsy are primarily done to look for cancer detection or to detect rejection of transplanted organ draft.

Biopsy is done to identify likely cause of cancerous and non-cancerous tissue, which are unable to detect through CT-scan or X-rays. Depending on area of sample collection various biopsy procedures are done such as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy, liver biopsy, and prostate biopsy. Furthermore biopsy can be done using needle biopsy, CT guided biopsy, Ultrasound biopsy, and surgical biopsy for the tissue diagnostic. According to the American journal of Nephrology, 2015, Australia has the highest numbers of annual renal biopsy rates (215 persons/million person/year) followed by the Finland (176 persons/million person/year) and U.S. (175 persons/million person/year). The increased numbers of biopsy procedure likely to fuel the growth of tissue diagnostic market, in near future.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1112

Rising prevalence of different cancer incidences is major driving factor boosting the tissue diagnostic market. According to American cancer Society (ACS), 1.6 million new cases of cancer diagnosed in the U.S., in 2016. In addition, increase research funding in cancer treatment and growing healthcare expenditure likely to show gradual rise in tissue diagnostic market. National Cancer Institute, in 2015, spends US$ 4,480 million on various types of cancer research which includes breast cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, leukemia, ovarian cancer and uterine cancer.

Tissue diagnostic market taxonomy:

By Product Type:

• Instruments
• Tissue processors
• Microtomes
• Cryostats
• Slide warmers
• Paraffin dispenser
• Biological microscopes
• Embedded center modules
• Strainers
• Consumables
• Stains
• Paraffin
• Cassettes
• Autopsy & dissection
• Slides

By Technology:

• In situ hybridization
• Digital pathology
• Immunohistochemistry
• Tissue microarray
• Special staining

By Disease:

• Breast cancer
• Lymphoma cancer
• Gastric cancer
• Prostate cancer

By End user:

• Research laboratories
• Hospitals
• Contract research organizations

Rise in the prevalence of cancer incidences to boost the tissue diagnostic market

According to the United States Cancer statistics report published in 2014 by Centers of Disease Control and Prevention (CDC), between 1999 and 2014, more than 1600 people a day, died due to the cause of cancer. Although screening tests helps to detect cancer condition at early stage, data from Healthy People 2020, an initiative form Department of Health and Human Services, reveals that screening rate is still below the national targets set. Combined data collected from CDC and National cancer institute (NCI) focus on the top 3 cancer incidences in male and female. In male prostate cancer incidence are higher, while in females breast cancer are most dominated, followed by lung and colon cancer respectively in both male and female.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/tissue-diagnostic-market-1112

New and advanced methods of tissue diagnosis favors the market growth

Innovation in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence in situ hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the opportunity to grow tissue diagnostic market in future. In September 2017, researchers at the University of Texas, developed a new way of diagnosis by creating pen named as “MasSpec Pen”, which is handheld devices able to distinguish healthy tissue and tumor tissue in just 10 seconds, more than 150 times quicker than existing technology. These new tool provides improvement in cancer treatment and minimizes the chances of recurrence by offering precise diagnostic information, which eventually favors the growth in tissue diagnostic market.

Key players operated in the tissue diagnostic market are Biocare Medical, Agilent technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp., Biogenex Laboratories, Life Technologies and Abbott laboratories.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Pharmacovigilance Market, by Clinical Trial, Types Of Reporting, Service Provider, and End User - Trends, Outlook, and Opportunity Analysis, 2025

Pharmacovigilance is a study of safety and efficacy of a medical product or drug. It is a science associated with the collection, detection, assessment, and prevention of adverse effects related with the medical product or drug. The role of pharmacovigilance is to analyze the side effects of the drug and determine the adverse effects, negatively affecting the drug’s efficacy and vice-versa. Pharmacovigilance comprises drug discovery and development, preclinical research, clinical research, and post marketing surveillance. It traces every phase of a drug cycle from preclinical development to post-market surveillance. Increasing prevalence of adverse drug reaction and implementation of safety regulations by government regulatory bodies is expected to fuel growth of the pharmacovigilance market over the forecast period.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1047

Growing prevalence of adverse drug reactions is expected to fuel pharmacovigilance market growth over the forecast period

Growing prevalence of adverse reactions caused by drugs, has influenced the pharmaceutical and biotechnological industries to adapt practices of pharmacovigilance, is in turn, expected to fuel growth of the market for pharmacovigilance in the near future.

Government regulatory bodies such as the U.S. Food and Drug Administration (U.S.-FDA) and European Medicines Evaluation Agency (EMEA) have formulated safety regulations to ensure manufacture of safe drugs and evaluation of its after-effects on patients. These regulations have to be followed by pharmaceutical and biotechnological companies, in turn, fueling demand for pharmacovigilance. Moreover, increasing R&D in the drug sector is further expected to propel growth of the pharmacovigilance market.

Global Pharmacovigilance Market Taxonomy

On the basis of clinical trial, the global pharmacovigilance market in segmented into:

• Preclinical Studies
• Phase I
• Phase II
• Phase III
• Phase IV or Post Marketing Surveillance

On the basis of types of reporting, the global pharmacovigilance market in segmented into:

• Spontaneous Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• Intensified ADR Reporting
• EHR Mining

On the basis of service provider, the global pharmacovigilance market in segmented into:

• Contract Outsourcing
• In-house

On the basis of end user, the global pharmacovigilance market in segmented into:

• Medical Device
• Biotechnological
• Pharmaceutical

Europe is expected to hold a dominant position in the global pharmacovigilance market, due to introduction of new legislation in European Union

Europe is expected to hold a dominant position in the global pharmacovigilance market, over the forecast period. This is mainly due to introduction of new legislations in European Union in 2012, which ensures good vigilance practices for pharmaceutical companies and medicines regulators.. According to National Center for Biotechnology Information, in 2016, Europe accounted for high incidence of adverse drug reactions, around 5% of all hospital admissions were due to drug reactions, which caused around 197,000 deaths in EU. Increasing prevalence of adverse drug reactions and introduction new legislation has influenced adoption of pharmacovigilance among companies, in turn, fueling the market growth in the region. North America is expected to hold the second-largest market for pharmacovigilance due to increasing development of new drugs and growth in research and development activities of pharmaceutical and biotechnology in the U.S.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/pharmacovigilance-market-1047

Key Players in the Pharmacovigilance Market

PharmaLex, a development consulting and affairs group has collaborated with Volv to boost its pharmacovigilance business. Key players operating in the global pharmacovigilance market include Accenture, Cognizant, PAREXEL International Corporation, IBM Corporation, Clinquest Group B.V., Wipro Ltd, Oracle Corporation, Foresight Group International AG, TAKE Solutions Ltd, and United BioSource Corporation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Microfluidic Market to Surpass US$ 13.8 Billion Threshold by 2025

The Global Microfluidic Market, by Material Type (Silicon-Based Microfluidic, Glass-Based Microfluidic, Polymer-Based Microfluidic, and Others), by Application (In Vitro Diagnostic Devices, Drug Delivery Devices and Monitoring Devices), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2.8 billion in 2016 and is projected to exhibit a CAGR of 19.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Increasing adoption of microfluidic technology to produce miniaturized microfluidic chips used in molecular diagnosis and analysis, is expected to boost growth of the microfluidic market. For instance, in March 2016, 908 Devices Inc. launched, ZipChip, a microfluidic device that provides high quality separation possibilities to mass spectroscopy enabling fast analysis for a broader range of biomolecules.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1086

Advancement in microfluidics technology such as lab-on-a-chip is expected to propel growth of the market

Advancement in microfluidic technology such as sample droplet production technique, microfluidic sensors, lab-on-a-chip, microfluidic enabled microscope, and microfluidic valve controller helps to further augment growth of the microfluidic market. Moreover technology advancement in microfluidic saves the time, eliminate the need of expensive laboratory robots and reduce the risk of sample loss and contamination. For instance, in February 2017, researchers at the Stanford University School of Medicine have developed a relatively cheap and reusable diagnostic lab-on-a-chip for medical diagnostic application, which is expected to enhance the diagnostic capabilities and would be a highly feasible option in emerging economies.

Rising adoption of microfluidic technology in drug delivery systems is expected to accelerate demand for microfluidics

Controlled drug delivery system deliver the drug at target sites, in desired quantity, and on time thus, enhancing drug efficiency, bioavailability, and pharmacokinetics while maintaining minimum side effects. Microfluidic-based devices are adopted significantly for micro and nano-scale drug delivery, maintaining the physiochemical characteristics of drug, at the target location. For instance, researchers at the Massachusetts Eye and Ear Infirmary, Harvard Medical School and Charles Stark Draper Laboratory in Massachusetts developed microfluidic based automated micropump device for direct delivery of drugs into the perilymph fluid within the cochlea- an auditory portion of the inner ear.

Key players in the microfluidic market are emphasizing on introducing innovative solutions based on microfluidic technology for a wide range of applications. For instance, in November 2017, Dolomite Bio introduced Nadia- a single-cell platform for single-cell RNA sequencing. Nadia is droplet microfluidic based instrument that can generate 6,000 single-cell libraries per sample in just 15 minutes. It also aids researchers to run multiple samples parallelly. Dolomite Bio combines the microfluidic technology with automated temperature control and cell/bead agitation in single instrument that delivers highly precise and reliable results. OPKO Health, Inc., in November 2017 submitted the Premarket Approval (PMA) application to US FDA for Claros 1 immunoassay analyzer. Claros 1 immunoassay analyzer is a diagnostic instrument system, which uses microfluidics technology to provide quick and quantitative blood test result in just 10 minutes by eliminating the need of external reagent, instrument calibration and maintenance.

Browse 30 Market Data Tables and 35 Figures spread through 190 Pages and in-depth TOC on “Microfluidic Market”- Global Forecast to 2025

To know the latest trends and insights prevalent in the Microfluidic market, click the link below: https://www.coherentmarketinsights.com/market-insight/microfluidic-market-1086

Key Takeaways of the Microfluidic Market:

• The global microfluidic market is expected to exhibit a CAGR of 19.4% over the forecast period, owing to the increased cardiovascular disease. For instance, in 2014, cardiovascular disease was the leading cause of death in China, accounting for around 42.60% and 44.52% of all deaths in rural and urban areas respectively. The other factors effecting the rise in microfluidic market are, increasing geriatric population and advancement in POC testing devices.
• Among materials, the polymer-based microfluidic material segment is expected to account for major share over the forecast period. This is attributed to cost-effective, simple, and disposal advantage of these materials for total analysis system and lab-on-a-chip (LOC) devices.
• Among application, the drug delivery devices segment is expected to be dominant in the microfluidic market over the forecast period, owing to factors such as safe, user-friendly, and controlled drug delivery of biomolecules of the systems.
• Some of the major players operating in the global microfluidic market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc., Siemens Healthcare GmbH, and Micronit Microfluidic BV

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Brain Health Devices Market, By Product Type, Application - Global Trends, and Forecast 2017 - 2025

Brain health devices are used in the treatment of neurological disorders such as Alzheimer disease and other dementias, epilepsy, cerebrovascular diseases, including stroke, migraine, and other headache disorders, Parkinson’s disease, multiple sclerosis, neuroinfections, brain tumors, traumatic disorders of the nervous system due to head trauma and neurological disorders as a result of malnutrition. Neurological disorders may also occur due to various infections such as viral infection (Zika virus), bacterial infection (Neisseria meningitides), and fungal infection (Cryptococcus). According to the World Health Organization (WHO), in 2016, around 450 millions of people were affected by neurological disorders across the world. Around 50 million people were reported to be suffering from epilepsy across the globe and over 6 million people die due to stroke each year. Brain health devices such as CT scan, MRI, EEG, MEG, Transcranial Doppler (TCD) devices are commonly used to monitor brain activity.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1095

Rising prevalence of Alzheimer’s disease is expected to boost market growth

The major factor contributing to growth of the brain health devices market is the rising number of Alzheimer’s cases. For instance, According to the Alzheimer’s Association, in 2017, over 5 million people are estimated to be suffering from Alzheimer’s disease, which is also reported to be the sixth-leading cause of death in the U.S. Furthermore, growing geriatric population, rising number of traumatic brain injury cases, and rampant advancements in technology such as brain biomarkers, gene therapy, stem cell therapy and smart brain prosthetics are contributing to growth of the brain health devices market. Furthermore, diagnosis and treatment neurodegenerative diseases through the microbiome and neuroimaging techniques further augments market growth. However, high costs of these devices are responsible for hindering market growth.

Brain Health Devices Market Taxonomy:

The global brain health devices market is segmented on the basis of devices, application, end user, and geography

On the basis of devices, the global brain health devices market is segmented into

• Magnetic Resonance Imaging
• Magneto Encephalogram
• Computed Tomography
• Electro Encephalogram
• Intracranial Pressure Monitors
• Transcranial Doppler Devices

On the basis of application, the global brain health devices market is segmented into

• Stroke
• Epilepsy
• Headache Disorders
• Dementia
• Parkinson’s disease
• Traumatic Brain Injuries
• Dyslexia
• Others

On the basis of end user, the global brain health devices market is segmented into

• Hospitals
• Specialty Clinics
• Others

On the basis of region, the global brain health devices market is segmented into North America, Latin America, Europe, Asia pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global brain health devices market, owing to rising number of traumatic brain injury cases in the U.S. For instance, According to the Centers for Disease Control and Prevention in 2013, around 282,000 people were diagnosed with brain injury and around 50,000 people died due to traumatic brain injury. It is estimated to be a major cause of disability and death in the U.S. Furthermore, high adoption of advanced technologies such as Pacifica, Pala-linq, and Spire and Fisher Wallace Stimulator have also contributed to growth of the brain health devices market in the U.S. Moreover, Asia Pacific is expected to be the fastest-growing region in the global brain health devices market.  According to the Journal of Nature, China launched brain imaging factory in 2017 that will help researchers to map neural connectivity for the studies of Alzheimer’s disease to brain inspired artificial intelligence projects.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/brain-health-devices-market-1095

FDA approval of the first handheld medical device Ahead 300 launched by BrainScope is expected to propel the brain health devices market

Major players involved in the global brain health devices market include BrainScope Company, Inc., Bio-Signal Group Corp., Cadwell Industries, Inc. Advanced Brain Monitoring, Inc., Compumedics Ltd., Elekta, DePuy Synthes, Electrical Geodesics, Inc., Medtronic, GE Healthcare, MEG International Services Ltd, Natus Medical, Inc., Neurowave Systems Inc., Nihon Kohden Corporation, and Philips Healthcare. The key players are focusing on strategic mergers and acquisitions and development of innovative products. For instance, in 2016, Food and Drug Administration (FDA) approved the first handheld medical device named Ahead 300, launched by BrainScope Company, Inc. for assessing traumatic brain injury.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Hypodermic Needles Market, By Product Type, Application - Global Trends, and Forecast 2017 - 2025

Hypodermic needles are hollow needles that are attached with hypodermic syringes for injecting saline solution or solution containing liquid medicines and drugs. These needles are also useful in extraction of fluids such as blood from the body. Hypodermic needles can be used as disposable as well as reusable needles. The reusable needles must be sterilized before use due to their ability to cause various diseases or infections that might transmit if they are not sterile. Disposable hypodermic needles aids an important role in research environments where sterile conditions are required and it also reduces contamination significantly during inoculation of a sterile substrate. Thus, preventing colonization of airborne pathogens on the needles surface. Hypodermic needles are primarily of two types, which include safety and non-safety hypodermic needles. Safety hypodermic needles are the needles on the safety syringe that can be permanently attached or detachable thus preventing healthcare professional from needle stick injuries. Whereas, non-safety hypodermic needles are the conventional syringe needles, which lack safety mechanisms thereby possessing higher chances of needle stick injuries.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1102

Rising demand for vaccines is expected to boost the hypodermic needles market

The factors that are contributing to the growth of hypodermic needles market are rising demand for intravenous vaccines delivery mode. There are numerous vaccines that are recommended for injection into muscle (intramuscularly) although some are delivered through subcutaneously and intradermally. Furthermore, increasing prevalence of chronic diseases and rising compliance for safety needles so as to curtail the incidences of needle stick injuries are the other factors that are contributing to the growth of hypodermic needles. However, rising incidence of needle stick injuries and risk of infections associated with administering drugs using hypodermic needles are hindering the growth of hypodermic needles market.

Hypodermic Needles Market Taxonomy:

Hypodermic Needles Market is segmented on the basis of Product type, end user, and geography

On the basis of product type, hypodermic needles market is segmented into:

• Safety hypodermic needle
• Passive hypodermic needle
• Retractable hypodermic needle
• Non- retractable hypodermic needle
• Active hypodermic needle
• Retractable hypodermic needle
• Non – retractable hypodermic needle
• Non safety hypodermic needle

On the basis of end user, hypodermic needles market is segmented into:

• Diagnostic Center
• Hospital
• Others

On the basis of region, hypodermic needles market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global hypodermic needles market, owing to the launch of new product called SafeTouch Safety Needle in 2016, by Nipro Medical Corporation, which is known to protect the patients from needle stick injuries. Furthermore, Asia Pacific is expected to witness a major traction in the global hypodermic needles market, owing to the conducive policies for the approval of new injectable and increasing technological advancements. For instance, Microdermics in 2017 has developed a novel commercially scalable, low-cost, customizable, metal, hollow, and microneedle platform that provides efficient delivery of vaccines and biologics.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/hypodermic-needles-market-1102

The innovative K pack Surshield launched by Terumo Medical Corporation is expected to propel the market growth

The key players in the hypodermic needles market include Albert David, Becton, Connecticut Hypodermics, Retractable Technologies, Novo Nordisk, BD, Covidien, Terumo Medical Corporation, Dickinson, Vygon, Vita Needle Company, Unilife Corporation, Hindustan Syringes & Medical Devices Limited, and Nipro Medical Corporation. The key players are focusing on strategic mergers and acquisition and development of innovative systems. For instance, Terumo Medical Corporation has launched an innovative hypodermic needle known as K-Pack Surshield in 2012, which has an integrated passive sharps protection feature with pre filled syringes. The device is used to allow automated manipulations during the packaging process, which makes it ideal for inclusion and bundling into the secondary packaging of parenteral medication.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.